Related Experiment Video
Updated: Apr 10, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
[Clinical characteristics of 15 cases of microscopic polyangiitis associated with alveolar hemorrhage]
1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;
Objective:
To investigate the clinical features of patients with microscopic polyangiitis (MPA) and alveolar hemorrhage (AH), so as to raise the physicians' understanding of this condition.
Methods:
The clinical data of 15 MPA patients combined with AH, who were hospitalized in Peking Union Medical College Hospital from January 2008 to January 2014, were retrospectively analyzed.
Results:
These 15 subjects accounted for 18.1% of all MPA patients, including 4 males and 11 females with mean age of (59.4 ± 17.9) years old and mean disease duration of 7.5 (1-48) months. Hemoptysis or bloody sputum (14/15) and dyspnea (11/15) were predominant pulmonary manifestations. Hypoxemia appeared in 6 patients (40.0%). An average 8-46 (22.7 ± 4.4) g/L drop of hemoglobin level was seen in all 15 patients. Imaging revealed new bilateral infiltrations or opacities in 13 cases, and bloody bronchoalveolar lavage fluid were found in 6 cases. Compared with MPA patients without AH, the incidence of myalgia [2/15 vs 50.0%(34/68); P=0.009, OR=0.154] and hemoglobin level [(83.2 ± 21.0) g/L vs (102.5 ± 18.7) g/L; P=0.001] were statistically lower in MPA patients with AH. There were no statistical differences in age, sex, interstitial lung disease, renal involvement, peripheral neuropathy and the five factor score between two groups. The proportion of patients who received corticosteroid pulse treatment in MPA with AH group was significantly higher than that of MPA patients without AH [9/15 vs 19.1%(13/68); P=0.003, OR=6.346]. After treatment, 13 cases achieved remission, while 2 died.
Conclusion:
As an important pulmonary manifestation of MPA, AH could be insidious but fatal. The treatment with steroid, cyclophosphamide and plasma exchange could improve the prognosis.
Insights
Microscopic polyangiitis (MPA) with alveolar hemorrhage (AH) presents with severe pulmonary symptoms and lower hemoglobin levels. Early diagnosis and treatment with steroids, cyclophosphamide, and plasma exchange can improve outcomes in patients with MPA and AH.
Area of Science:
- Rheumatology
- Pulmonology
- Internal Medicine
Background:
- Microscopic polyangiitis (MPA) is a systemic vasculitis that can affect the lungs.
- Alveolar hemorrhage (AH) is a rare but serious pulmonary manifestation of MPA.
Purpose of the Study:
- To investigate the clinical features of patients with microscopic polyangiitis (MPA) and alveolar hemorrhage (AH).
- To enhance physicians' understanding and recognition of this condition.
Main Methods:
- Retrospective analysis of clinical data from 15 MPA patients with AH.
- Comparison of clinical features between MPA patients with and without AH.
Main Results:
- MPA with AH patients presented with hemoptysis, dyspnea, and hypoxemia.
- Lower hemoglobin levels and reduced incidence of myalgia were observed in MPA with AH patients compared to those without AH.
- A higher proportion of MPA with AH patients received corticosteroid pulse therapy.
Conclusions:
- Alveolar hemorrhage is a potentially fatal pulmonary manifestation of MPA.
- Treatment with steroids, cyclophosphamide, and plasma exchange can improve prognosis in MPA patients with AH.
More Related Videos
09:28Intravital Widefield Fluorescence Microscopy of Pulmonary Microcirculation in Experimental Acute Lung Injury Using a Vacuum-Stabilized Imaging System
Published on: April 6, 2022
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Nephrotic Syndrome I : Introduction
Peripheral Artery Disease I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Atypical Pneumonia
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation